Slow Capital Inc. Raises Stock Holdings in GRAIL, Inc. $GRAL

Key Points

• Slow Capital Inc. increased its stake in GRAIL, Inc. by 5.1%, now holding 142,840 shares worth approximately $7.35 million.
• GRAIL's latest earnings showed a miss on EPS estimates at ($3.18) and revenue of $35.54 million, below the expected $37.57 million.
• Brokerage firms have varied opinions on GRAIL, with Canaccord Genuity raising its price target to $75.00 while Weiss Ratings issued a sell rating.

Slow Capital Inc. lifted its stake in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 5.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 142,840 shares of the company's stock after acquiring an additional 6,883 shares during the period. GRAIL accounts for approximately 0.9% of Slow Capital Inc.'s portfolio, making the stock its 29th biggest holding. Slow Capital Inc. owned 0.40% of GRAIL worth $7,345,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in GRAL. Caldwell Sutter Capital Inc. purchased a new position in GRAIL in the 1st quarter valued at about $28,000. KBC Group NV lifted its stake in shares of GRAIL by 187.7% during the first quarter. KBC Group NV now owns 1,430 shares of the company's stock valued at $37,000 after buying an additional 933 shares during the period. S.A. Mason LLC lifted its stake in shares of GRAIL by 50.1% during the first quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock valued at $38,000 after buying an additional 500 shares during the period. Farther Finance Advisors LLC boosted its position in GRAIL by 768.1% during the second quarter. Farther Finance Advisors LLC now owns 816 shares of the company's stock worth $42,000 after acquiring an additional 722 shares during the last quarter. Finally, NewEdge Advisors LLC grew its stake in GRAIL by 390.3% in the 1st quarter. NewEdge Advisors LLC now owns 1,760 shares of the company's stock worth $45,000 after acquiring an additional 1,401 shares during the period.

GRAIL Trading Down 5.9%

Shares of GRAL opened at $61.70 on Tuesday. GRAIL, Inc. has a twelve month low of $12.33 and a twelve month high of $73.74. The firm has a market capitalization of $2.22 billion, a P/E ratio of -4.71 and a beta of 4.11. The stock's fifty day simple moving average is $39.16 and its 200 day simple moving average is $37.47.

GRAIL (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings results on Tuesday, August 12th. The company reported ($3.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($3.14) by ($0.04). The firm had revenue of $35.54 million for the quarter, compared to analysts' expectations of $37.57 million. GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. Sell-side analysts predict that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Insider Buying and Selling

In other GRAIL news, CFO Aaron Freidin sold 8,000 shares of GRAIL stock in a transaction that occurred on Tuesday, July 15th. The shares were sold at an average price of $38.93, for a total transaction of $311,440.00. Following the transaction, the chief financial officer directly owned 286,020 shares of the company's stock, valued at $11,134,758.60. The trade was a 2.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, President Joshua J. Ofman sold 9,692 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $64.00, for a total transaction of $620,288.00. Following the completion of the sale, the president directly owned 478,182 shares of the company's stock, valued at $30,603,648. The trade was a 1.99% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 21,894 shares of company stock valued at $1,066,276.

Analyst Ratings Changes

A number of brokerages have weighed in on GRAL. Canaccord Genuity Group increased their price target on GRAIL from $43.00 to $75.00 and gave the stock a "buy" rating in a research note on Friday. Weiss Ratings reiterated a "sell (d-)" rating on shares of GRAIL in a research note on Saturday, September 27th. Finally, UBS Group set a $75.00 target price on GRAIL in a research report on Friday. One research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $56.67.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.

Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GRAIL, Inc. (NASDAQ:GRAL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.